李子園(605337.SH)擬以募集資金向子公司提供借款實施募投項目
格隆匯3月9日丨李子園(605337.SH)公佈,根據《招股説明書》,公司募集資金投資項目的實施主體均為公司的全資子公司鶴壁李子園和雲南李子園,為保障募集資金投資項目的順利實施以及便於公司的管理,公司擬使用募集資金分別向鶴壁李子園和雲南李子園提供無息借款2.62億元、1.32億元,借款期限自相關議案通過董事會決議之日起三年內有效,上述無息借款在借款額度及借款期限內視募集資金投資項目的實際進展及需求分期匯入《募集資金專户四方監管協議》對應賬户,根據項目建設的實際情況,借款到期後可續借或者提前償還。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.